Clinical trial
Gemcitabine Plus High-Dose 5-Fu/Leucovorin in the Treatment of Advanced or…
NCT00201305 · National Health Research Institutes, Taiwan, Other · Completed
Key facts
| NCT number | NCT00201305 |
|---|---|
| Title | Gemcitabine Plus High-Dose 5-Fu/Leucovorin in the Treatment of Advanced or Metastatic Carcinoma of the Biliary Tract |
| Official title | Prospective Phase II Randomized Trial-Weekly Gemcitabine Plus High-Dose 5-Fluorouracil/ Leucovorin in the Treatment of Advanced or Metastatic Carcinoma of the Biliary Tract |
| Lead sponsor | National Health Research Institutes, Taiwan, Other |
| Collaborators | Chang Gung Memorial Hospital Changhua Christian Hospital China Medical University Hospital Mackay Memorial Hospital Chi Mei Medical Hospital Taipei Veterans General Hospital, Taiwan National… |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Biliary Tract Disease |
| Intervention type | Drug |
| Interventions | Gemcitabine+5FU+Leucovorin |
| Enrollment | 50 |
| Start date | Jul 1, 2002 |
| Completion | Aug 1, 2012 |
| First posted | Sep 20, 2005 |
| Last update posted | Apr 1, 2009 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: